Patients are at the center of all we do

At Clinigen US, we focus on improving the lives of people who—often unwittingly—become patients when they are diagnosed with a disease or condition. Their journey is often emotional, and not always easy. Whether we are bringing a therapeutic to the US market—or helping other companies increase access to their products—patients are our priority.










Alone we can do so little; together we can do so much.

Helen Keller








Powerful mission

We are dedicated to ensuring that the right medicine gets to the right patient, at the right time.

This means helping patients—and the healthcare professionals who care for them—by providing crucial therapeutics that address both known and unmet medical needs. We also help in gaining access to medicines without delays, through clinical trials (including compassionate use), or via patient assistance programs.

These and other Clinigen US solutions can make a huge difference in the lives of patients, especially those with rare diseases or difficult-to-treat conditions.

Our history

When our UK-headquartered parent company (Clinigen Group plc) went global in 2008, the United States was the first target market.

Yardley, Pennsylvania, was a natural choice for our US headquarters. It is a hub for many of the nation’s leading pharmaceutical and biotechnology companies. After the overwhelming success of Clinigen US, global offices in over 10 countries soon followed.

Today, new and expanding opportunities make Clinigen US a:
  • Proven company for successful business partnerships
  • Profitable company with an innovative pipeline to benefit investors
  • Premier company for career-seeking professionals